JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmitz, M. L.
Right arrow Articles by Baeuerle, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmitz, M. L.
Right arrow Articles by Baeuerle, P. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 26, Issue of June 30, pp. 15576-15584, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Transactivation Domain 2 (TA) of p65 NF-B
SIMILARITY TO TA AND PHORBOL ESTER-STIMULATED ACTIVITY AND PHOSPHORYLATION IN INTACT CELLS (*)

M. Lienhard Schmitz (§) , Marcos A. dos Santos Silva (¶) , Patrick A. Baeuerle

From the (1)Institute of Biochemistry, Albert-Ludwigs-University, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

The p65 subunit of the inducible transcription factor NF-B contains at least two strong transactivation domains (TADs) within its C terminus. The first domain, TA, is contained within the last 30 amino acids of p65, whereas TA comprises the adjacent 90 amino acids. In this study, squelching experiments revealed that both TADs of p65, as well as the related subunit c-Rel, compete for the same cofactor(s) mediating transactivation. Both TADs of p65 share a common sequence motif, which is evolutionarily conserved and displays a remarkable degree of spatial organization when aligned on an -helical surface. The functional importance of the common sequence motif was confirmed by deletion analysis of TA. Within the conserved sequence motif, a 7-amino-acid repeat was noted. Idealized heptad repeats fused to the DNA binding domain of Gal4 were transcriptionally active, but only as multimers. Phosphorylation and transcriptional activity of a defined region within the TA domain was found to be stimulated by phorbol ester treatment of cells. In contrast, TA was constitutively phosphorylated, and its activity did not significantly respond to phorbol ester stimulation. The stimulatory effect of phorbol ester on transcription of the TA domain was completely blocked by the protein kinase C inhibitor. These data suggest that protein kinase C has a dual effect on NF-B activity. It not only causes removal of IB- from cytoplasmic NF-B but also augments the transactivation potential of activated nuclear NF-B.


INTRODUCTION

Gene expression in higher eucaryotes is governed by transactivating polypeptides which bind in a sequence-specific manner to cis-regulatory elements of DNA. A paradigm for an inducible transcriptional activator is nuclear factor B (NF-B).()This protein can rapidly activate numerous target genes encoding proteins involved in inflammatory, immune, and acute phase responses (reviewed by Baeuerle and Henkel(1994) and Thanos and Maniatis(1995)). The DNA binding form of NF-B is composed of two subunits. Molecular cloning revealed that the DNA-binding subunits of NF-B in mammals comprise five proteins encoded by a novel multigene family. The subunits contain a conserved region, approximately 300 amino acids in length in their N terminus, which is responsible for DNA binding, dimerization, and nuclear localization (reviewed by Blank et al.(1992) and Schmitz and Baeuerle(1995)). The most abundant form of NF-B consists of p50 and p65 heterodimers. NF-B is located in the cytoplasm of many cell types in an inducible form, in which the heterodimer is complexed to the inhibitory subunit IB (Baeuerle and Baltimore, 1988). IB has been shown to mask the nuclear location signals of both DNA-binding subunits, thus preventing their nuclear uptake (Beg et al., 1992; Zabel et al., 1993). Stimulation of cells with numerous pathogenic agents leads to rapid proteolytic degradation of IB (Beg et al., 1993; Henkel et al., 1993; Sun et al., 1993). Within minutes, the released nucleophilic heterodimer is then transported to the nucleus, binds to its cognate DNA, and induces gene transcription.

p65, RelB, and c-Rel are transcriptionally active members of the NF-B family, whereas p50 and p52 primarily serve as mere DNA-binding subunits (reviewed by Liou and Baltimore(1993)). The respective TADs of p65, RelB, and c-Rel are contained in their unique C-terminal portions. RelB has additional transactivating sequences in its N terminus (Rysek et al., 1992). p65 was shown to contain at least two independent TADs within its C-terminal 120 amino acids (Schmitz and Baeuerle, 1991; Ballard et al., 1992; Fujita et al., 1992; Moore et al., 1993; Ruben et al., 1992). One p65 activation domain, TA, is confined to the terminal 30 amino acids. The second domain, TA, is contained within the N-terminally adjacent 90 amino acids (Schmitz and Baeuerle, 1991). The TAD of murine c-Rel has been localized between amino acids 403 and 568 (Bull et al., 1990).

In contrast to our detailed knowledge of DNA binding domains, our current understanding of the structure of TADs is relatively poor. TADs have been classified according to their predominant amino acid composition as proline-rich, glutamine-rich, or acidic (reviewed by Mitchell and Tjian(1989)). The structure of acidic TADs is a matter of debate. They have been suggested to exist as unstructured ``acidic blobs'' (Sigler, 1988)), amphipathic -helices (Giniger and Ptashne, 1987), and -sheets (Leuther et al., 1993; Van Hoy et al., 1993). It seems that only under certain experimental conditions, acidic TADs adopt a defined secondary structure. As revealed by CD spectroscopy, an -helix is induced in the case of the AH domain (Van Hoy et al., 1993), VP16 (Donaldson and Capone, 1992), p65 TA (Schmitz et al., 1994), and a -sheet in the case of GCN4 (Leuther et al., 1993; Van Hoy et al., 1993).

TADs have also been classified with respect to several functional criteria. For instance, it was found that different classes of TADs behave differently in histone H1 anti-repression assays (Croston et al., 1991). A further functional difference is based on the observation that acidic activation domains and those rich in serines and threonines are functional in yeast cells, whereas glutamine-rich domains are not (Berger et al., 1992). Activation domains can also be grouped according to their ability to activate transcription from remote or proximal promoter positions (Seipel et al., 1992). Biochemical studies showed that different TADs contact different target molecules. For example, it was shown that the glutamine-rich TAD of Sp1 specifically contacts TAF110 (Hoey et al., 1993), whereas the acidic activation domain of the herpes virus VP16 protein was shown to contact TBP (Stringer et al., 1990) and TFIIB (Lin et al., 1991), as well as TAF40 (Goodrich et al., 1993). Further evidence for functional differences of TADs was obtained in so-called squelching experiments, where the activity of a given TAD is influenced by the simultaneous overexpression of a second TAD (reviewed by Ptashne(1988)).

In this study, we show by squelching assays that both TADs of NF-B p65 mutually interfere with their activating function, suggesting that they belong to the same class of acidic TADs. This observation led to the discovery of an evolutionarily conserved sequence motif present in both TA and TA of p65. This motif is shown to be necessary, but not sufficient for proper TA function. Within the conserved motif, a heptapeptide repeat was found. An idealized heptad repeat sequence was able to activate transcription, but only as a multimer. Both TADs of p65 were found to be phosphorylated in intact cells. Both the activity of TA and its phosphorylation status were increased upon stimulation of cells with phorbol 12-myristate 13-acetate (PMA). In contrast, TA did not significantly respond to PMA. This suggests that the activity of NF-B can be further modulated by phosphorylation of its active nuclear form.


MATERIALS AND METHODS

Cell Culture, Transfections, and CAT Assays

Monkey COS-7 cells were grown at 37 °C in Dulbecco's modified Eagle's medium, supplied with 1% penicillin/streptomycin and 10% fetal calf serum (all from Life Technologies, Inc.). For transfection of COS cells, approximately 5 10 of exponentially growing cells were transfected with 2 pmol of the reporter construct and 0.5 pmol of the expression plasmid. All plasmids used for transfection experiments were purified twice on CsCl gradients. Cells were transfected in suspension (Lopata et al., 1984) and then plated on 10-cm dishes. After another 48 h of growth, cells were harvested and extracts were prepared. The protein concentration was determined by the method of Bradford (Bradford, 1976), and equal amounts of protein were assayed for CAT activity as described (Pierce et al., 1988). The acetylated and nonacetylated forms of [C]chloramphenicol were separated by thin layer chromatography, and the incubation conditions were chosen to result in conversion of [C]chloramphenicol not exceeding 60%. Transfections were performed at least in duplicate, and the results were quantified by liquid scintillation counting. Each construct was tested in at least 3 independent experiments. For squelching experiments, between 5 and 10 10 COS cells were transfected as described above with 4 pmol of reporter plasmid, 0.25 pmol of the Gal4 fusion construct, and routinely with 3 pmol of either the squelching plasmid or control vector (pRc/CMV, Invitrogen). After transfection, cells were plated onto 6-cm dishes and allowed to grow for another 36-48 h. In the PMA induction experiments, 1 10 COS cells were transfected with 4 pmol of reporter plasmid, 1 pmol of the Gal4-p65 fusion construct, and 1 pmol of a RSV-lacZ construct. After transfection, the cells were split onto two 6-cm dishes and incubated for another 10 h. One of the dishes was treated with 20 ng/ml PMA (Sigma; dissolved in dimethyl sulfoxide), and cells were incubated for another 16-20 h. Subsequently, the cells were harvested, and an aliquot was assayed for -galactosidase activity. Equal amounts of cell extracts normalized for -galactosidase activity were then assayed for CAT activity and compared directly. The protein kinase C inhibitor bisindolylmaleimide (Boehringer Mannheim) was dissolved in dimethyl sulfoxide and added in concentrations between 1 and 5 µM simultaneously with PMA to the cells.

Constructs

Details about the construction of the clones presented in this paper can be obtained from the authors upon request. The constructs RSV-GHF-1 (Theill et al., 1989), Gal4-VP16 (Schmitz and Baeuerle, 1991), and the Gal4- (Baniahmad et al., 1992) and NF-B-dependent reporter plasmids (Pierce et al., 1988) have been described previously. All clones were verified by restriction analysis and sequencing on the automated sequencer Genesis 2000 (DuPont NEN). Expression and DNA binding activity of each Gal4 fusion construct was ensured by monitoring the migration of the nuclear Gal4 fusion proteins in band-shift experiments using a P-labeled oligonucleotide containing a Gal4 binding site.

Electrophoretic Mobility Shift Assays

5 10 COS cells were transfected with the respective Gal4 fusion constructs and harvested 48 h later. Cells were washed with phosphate-buffered saline and transferred to a precooled Eppendorf tube after being scraped off the plate with a rubber policeman. Cells were pelleted by centrifugation at 4 °C for 2 min at 400 g. The pellet was resuspended in 5 EB buffer (100 mM Tris/HCl, pH 7.5, 500 mM KCl, 25 mM MgCl, 35% (v/v) glycerol, 5 mM dithiothreitol, 0.5 phenylmethylsulfonyl fluoride, and 1% aprotinin). Cells were lysed by 2 cycles of freeze-thawing and subsequently centrifuged for 20 min at 4 °C at 100,000 g. Five to ten µg of protein was incubated with 1-2 µg of poly(dI-dC) (Sigma) and incubated with 10,000 cpm of a labeled oligonucleotide for 20 min on ice. The free and protein-bound oligonucleotides were separated on a 4% polyacrylamide gel containing 2% glycerol. Gel and running buffer were identical and contained 25 mM Tris, 25 mM boric acid, 0.5 mM EDTA, and 1 mM MgCl. The gel was dried after electrophoresis and exposed to a Kodak XAR5 film. The oligonucleotide used for electrophoretic mobility shift assays (EMSAs) contains a single Gal4 binding site, which is shown underlined.

On-line formulae not verified for accuracy

SEQUENCE I

This oligonucleotide has been labeled with [-P]ATP using T4 polynucleotide kinase (Boehringer Mannheim).

Immunoprecipitations and Western Blotting

COS cells were transfected in batch with 2 pmol of expression plasmid, plated onto 4 Petri dishes, and grown for 24 h. Two out of four dishes were then washed and incubated in phosphate-free medium. The medium was supplied with 1% penicillin/streptavidin and 5% fetal calf serum (Life Technologies, Inc.) dialyzed against 20 mM Tris/HCl, pH 7.9, and 100 mM KCl. Subsequently, the cells were grown for 4 h in phosphate-free medium containing 0.25 mCi of [P]orthophosphate/ml (Amersham). After another hour of incubation with or without 50 ng/ml PMA, cells were harvested with a rubber policeman after they had been washed twice in phosphate-buffered saline. After centrifugation at 4 °C with 400 g, the pellet was dissolved in 100 µl of IP buffer (20 mM Tris/HCl, pH 8, 150 mM NaCl, 0.5% Nonidet P-40, 0.1 mM phenylmethylsulfonyl fluoride, 10 mM sodium pyrocarbonate, 100 mM NaF, and 10 mM glucose 6-phosphate). The cells were subjected to two cycles of freeze-thawing and centrifuged for 15 min at 4 °C at 14,000 g. The supernatant was mixed with 3 µl of -Gal4 antibody (rabbit polyclonal antibodies, a kind gift of Mark Ptashne) and incubated on a rotating spinning wheel at 4 °C for 3 h. Subsequently, 80 µl of Protein A-Sepharose beads (Pharmacia) were added that have been preswollen for 20 min in 1 IP buffer and 10 µg of bovine serum albumin (Sigma). This mixture was again incubated on a spinning wheel at 4 °C for 1 h. The beads were washed 6 times with 1 IP buffer. Finally, the beads were boiled for 5 min in 80 µl of 1 SDS sample buffer, and proteins were separated on a SDS-gel. The gel was then dried and exposed to x-ray film at -80 °C.

Cells from one of the two dishes containing nonlabeled cells was also stimulated with PMA. For Western blotting, the proteins were transferred from the SDS gel onto a polyvinylidene difluoride membrane (Bio-Rad) in a semidry blot apparatus (Schleicher und Schüll) according to the instructions of the manufacturers. The detection of Gal4 proteins was performed by first washing the membrane twice in TBST (10 mM Tris/HCl, pH 8, 150 mM NaCl, 0.05% Tween 20) and a subsequent incubation in TBST containing 5% non-fat dry milk powder for 1 h. The membrane was then incubated in a small volume of TBST, containing a 1:500 dilution of the -Gal4 antibody. After a 4-h incubation at room temperature, the membrane was washed 8 times in TBST and incubated for another hour in TBST containing a 1:3000 dilution of the second anti-rabbit antibody coupled to horseradish peroxidase (Bio-Rad). After extensive washing, the bound antibodies were detected using the ECL system (Amersham), according to the manufacturer's instructions.


RESULTS

The TADs of NF-B p65 Rely on the Same Coactivator(s)

Squelching experiments were performed in order to assess the effect of overexpressing various TADs on p65-dependent transcription. An expression vector encoding the fusion protein Gal4-p65, containing the complete C terminus of p65 linked to the DNA binding domain of Gal4 (amino acids 1-147), was co-transfected with a Gal4-dependent reporter plasmid and an excess of various TAD expression vectors into COS cells. Co-expression of a 12-fold excess of RelADNA, a p65 mutant incapable of binding to DNA due to a lack of amino acids 79-95 (Schmitz et al., 1994), reduced transcription of Gal4-p65 to approximately one-fourth of the original activity (Fig. 1A, compare columns 1 and 2). Furthermore, two derivatives of RelADNA, RelADNATA, and RelADNATA were tested which lack the indicated TAD, but retain the respective second TAD. These two constructs were used in order to investigate whether both p65 TADs contact the same or different target molecules. Both co-expression of RelADNATA and RelADNATA interfered with RelA-mediated transcription (Fig. 1A, columns 3 and 4, respectively), suggesting that TA and TA contact the same target molecule(s). Overexpression of c-Rel also impaired transactivation by Gal4-p65 (Fig. 1A, column 5). Co-expression of the control plasmid RelADNATA, a RelADNA derivative lacking both TADs, did not significantly affect p65-mediated transactivation (Fig. 1A, column 6). The activity of Gal4-p65 also remained unaltered when the human growth hormone transcription factor GHF was overexpressed (Fig. 1A, column 7). The finding that both TADs of p65 contact the same molecule was confirmed by additional squelching assays. Experiments employing either Gal4-p65 (encompassing only the TA domain) or Gal4-p65 (encompassing only the TA domain) as activators and co-transfecting the identical squelching plasmids used in Fig. 1resulted in a comparable expression pattern. More or less identical results were obtained when the acidic activator Gal4-VP16 was used. Overexpression of both p65 TADs reduced its activity, indicating that they both belong to the same class of acidic activators as VP16 (Fig. 1B).


Figure 1: Squelching experiments. A, squelching of p65. In each column shown, the construct Gal-p65 was transfected together with a Gal4-dependent CAT reporter gene and one of the indicated squelching plasmids into COS cells. Column 1 received as a control an equal amount of control vector (pRc/CMV). A p65 mutant incapable of binding to DNA was co-transfected in column 2. Also, two derivatives of that construct lacking either TA (column 3) or TA (column 4) were tested. The effect of co-expression of an expression vector containing c-Rel is shown in column 5. The effect of the p65 mutant lacking both TADs is displayed in column 6, and the effect of co-expression of the transcription factor GHF in column 7. The different effectors were co-transfected in a 12-fold excess in one typical series of experiments shown here. B, squelching of VP16. In each column shown, the construct Gal4-VP16 was used as activator plasmid. The experimental conditions were the same as described for part A of this figure.



The observed squelching effects were dependent on the dose of the added squelching plasmid. A maximal inhibitory effect was reached at a 12-fold excess of the squelching plasmid over the activator plasmid. The amount of DNA-protein complex formed between the Gal4 fusion proteins and a P-labeled oligonucleotide containing a Gal4 binding site in mobility shift assays was not significantly affected by the amount of co-transfected squelching plasmids (data not shown).

A Common Sequence Motif in p65 TAand TA

The finding that both TADs of p65 behaved similarly in squelching experiments prompted us to search for sequence homologies between the two domains. By inspection, we noted the homology shown in Fig. 2A. The region within TA which was homologous to TA is referred to as TA`. As is evident from Fig. 2B, both homology regions are conserved between human (Ruben et al., 1991), mouse (Nolan et al., 1991), and Xenopus p65 (Kao and Hopwood, 1991), suggesting the functional importance of this evolutionarily conserved region. A recent study analyzing point mutants of TA showed that the homology region is important for TA function (Schmitz et al., 1994). Furthermore, this region was shown to form an -helix in a hydrophobic solvent, as revealed by CD spectroscopy. On the assumption that the TA` region can also form an -helical structure, both domains are shown displayed on a helical wheel (Fig. 2C). Only the regions free of helix-breaking amino acids are shown over a stretch of 18 amino acids. The only exception is the Xenopus TA region starting with a single glycine at position 1 of the helical wheel, but proceeding over the following 17 amino acids without any helix-breaking amino acids.


Figure 2: TA contains a domain homologous to TA. A, positions of two homology regions within p65. The DNA binding and dimerization domains in the N-terminal region of p65 are represented by the boxed areas. The locations of TA (filled box) and TA are shown in the C-terminal part of the molecule. The homology region within TA is designated TA` and is shown by the shaded box. The position of a potential leucine zipper is indicated by three repeats of L. The two sequences are aligned in the lower part of the figure. Identical positions are shown by solid bars, the conserved hydrophobic amino acids by dashed lines. The asterisk marks the C-terminal end of the p65 protein. B, TA and TA` are highly conserved in evolution. The respective homology regions were compared between human, mouse, and Xenopus p65 proteins. The sequence positions of the amino acids are indicated. The derived consensus sequence is shown at the bottom of the figure. Helix-breaking proline and glycine residues are underlined. The Y stands for any hydrophobic amino acid. C, helical wheel plot of TA and TA` sequences. The amino acids displayed in the innermost circle are from the TA region of human and mouse. The next circles show the TA sequence from Xenopus, the TA` sequence from human and mouse, and the outermost circle the TA` sequence from Xenopus. Identical or conserved positions are marked. Serines, hydrophobic, acidic, and other amino acids are highlighted by different shadings.



The wheel plot revealed a striking degree of similarity with respect to the spatial organization of amino acid residues (Fig. 2C). Five positions were strictly hydrophobic. Two of them had a highly conserved phenylalanine and leucine residue, respectively. The hydrophobic positions are interrupted by hydrophilic residues, many of which are acidic. Only one position in the plot was strictly acidic and would, in the primary structure, directly precede the highly conserved phenylalanine. We have previously described that Asp/Glu-Phe dipeptides are a key feature of acidic activation domains (Schmitz et al., 1994). Basic amino acids are not present. Another striking feature was the clustering of serine residues opposite the helix surface with the mixed acidic and hydrophobic positions. These structural characteristics support the notion that an -helical conformation of TA and TA (TA`) sequences is of functional importance.

TA`Is Necessary but Not Sufficient for the Activity of TA

The functional role of the TA` sequence for the activity of TA was investigated by constructing a series of p65-mutants in which the C-terminal portion of p65 was linked to the DNA binding domain of Gal4 (see Fig. 3). These constructs were co-transfected with a Gal4-dependent reporter construct into COS cells and tested for their ability to stimulate transcription. As shown in Fig. 3, the construct Gal4-p65, which contains the entire TA region, resulted in a 96-fold increased rate of transcription compared to Gal4 alone. This construct was nearly as active as the entire C terminus of p65, which is represented by the construct Gal4-p65 (see Fig. 3). Any deletion of sequences from the C terminus affecting the integrity of TA` led to a drastic decrease in the ability of TA to stimulate transcription. A comparison between mutants Gal4-p65 and Gal4-p65 showed that only the longer version which retains TA had a significant transactivating capacity. However, construct Gal4-p65, which contains the TA` without any flanking sequences, showed no significant transactivation potential, suggesting it was not as independently active as TA. The addition of either C- or N-terminally adjacent sequences to the TA` region in the constructs Gal4-p65 and Gal4-p65 increased the transcriptional potential of the TA region, but failed to fully restore the activity of TA. Only the construct Gal4-p65, containing C- as well as N-terminal flanking sequences, restored the full transcriptional activity of TA. These data show that TA` is necessary, but not sufficient for proper TA function.


Figure 3: Deletion analysis of the TA domain. The indicated sequences of p65 were fused to the DNA binding region of Gal4 (amino acids 1-147), which is shown as a striped box. The symbols used in this figure are identical with those used in Fig. 2A. The sequence positions of the fused p65 sequences, which are shown as boxed areas, are given on the left. The constructs were co-transfected with a Gal4-dependent reporter gene into COS cells and tested for their ability to stimulate transcription. The level of activation of the Gal4-p65 fusion protein was directly compared to the activity of Gal4 alone, which was given the arbitrary value of 1. The values are averaged from more than four independent experiments. The standard deviations did not exceed 15%. All constructs were verified by sequencing and found to be correctly expressed, as revealed by EMSA analysis of nuclear extracts.



TAand TA`Contain Two Copies of a Heptad Repeat with Copy-dependent Transcriptional Activity

The finding that TA as well as TA` are required for the transactivating activity of p65 prompted us to dissect their primary structure in more detail. As depicted in Fig. 4A, both TA and TA` contain an internally repeated sequence as shown for human TA (Fig. 4A, top). TA contains two copies of a repeat element with the consensus sequence DXDFSX ( = hydrophobic, X = any amino acid). The internal repeats from the homology regions of TA and TA` of human, mouse, and Xenopus p65 proteins are listed in Fig. 4A by decreasing fulfillment of the consensus sequence DFSSLLS. In TA and TA`, the repeats are separated by one nonconserved amino acid residue. The ability of the sequence motif DFSSLLS to activate transcription was tested by fusing it in various copy numbers with a serine residue as spacer to the DNA binding domain of Gal4. Such constructs were tested for their transcriptional activity upon co-transfection with a Gal4-dependent CAT reporter gene in COS cells. As shown in Fig. 4B, the fusion of the sequence SSDFS to Gal4 gave rise to a transactivation not exceeding that of Gal4 alone. Likewise, the sequence LLSSDFSSLLSSDFSSL, which comprises one complete repeat, failed to transactivate significantly. However, 4 copies fused to Gal4 gave a fusion protein with strong transcriptional activity. A construct bearing 6 copies was not significantly stronger in transcriptional activation. These results show that the repeats have the potential to form strong transactivators when multimerized, suggesting that they act in synergy.


Figure 4: Analysis of a redundant repeat motif within TA and TA` of p65. A, alignment of heptad repeats from TA and TA`. The top part of the figure highlights the two repeated motifs I and II in human p65 TA by bars. The lower part of the figure aligns heptad repeats from TA and TA` domains of different species. The repeats are ordered by decreasing similarity. A first order homology is in a dark gray box, a second order homology in a light gray box. Repeat II of Xenopus TA showed the best fulfillment of the consensus sequence and was chosen for multimerization experiments. B, multimers of a consensus heptapeptide repeat display strong transactivating activity. The indicated Gal4 effector plasmids were transfected into COS cells together with a Gal4-dependent reporter plasmid and assayed for their ability to stimulate transcription. The fused sequences of the effector plasmids are shown. Transactivation seen with Gal4 alone and with the respective fusion proteins is represented by the columns. Transcriptional activity is given as percent conversion of [C]chloramphenicol. The standard deviation is indicated by a bar and was obtained from 5 independent experiments.



The Activity of TACan Be Stimulated by PMA

We tested whether the activity of the transactivating C terminus of p65 was responsive to stimulation with PMA. COS cells were co-transfected with the construct Gal4-p65 and a Gal4-dependent reporter plasmid and treated with PMA. In PMA-stimulated cells, the transcriptional activity of the fusion protein was increased by a factor of 5 compared to control cells (Fig. 5A, lane 2). In order to delineate the region within the transactivating C terminus of p65 responsive to PMA, various other constructs were tested in COS cells. The activity of the TA domain could be stimulated weakly, not exceeding a factor of 2 (Fig. 5A, lane 3), while the construct Gal4-p65 (Fig. 5A, lane 4) was more strongly responsive to stimulation of cells with PMA. The transcriptional activity of Gal4 alone (Fig. 5A, lane 1), Gal4-p65 (data not shown), and Gal4-p65 (Fig. 5A, lane 5) were completely unaltered after stimulation with phorbol ester. These results define the region between amino acids 442 and 470 of p65 as necessary for the strong stimulatory effect of PMA on p65-dependent transcriptional activity. This region contains part of the mini-leucine zipper and repeat element I from the TA` region. EMSAs showed that PMA treatment did not alter the DNA binding activity of Gal4-p65 and Gal4-p65 (Fig. 5B), indicating that PMA treatment affected transactivation by p65 but not the DNA binding activity of the Gal4 fusion proteins. The amount of complexes formed between Gal4 protein and a P-labeled oligonucleotide containing a Gal4 binding site was very similar after treatment of cells with PMA.


Figure 5: The activity of TA can be stimulated by PMA. A, mapping of the PMA-responsive region. Different plasmids encoding various Gal4-p65 fusion proteins were co-transfected with a Gal4-dependent reporter plasmid into COS cells. Cells were split after transfection onto two dishes, one of which was stimulated with PMA. The left panel shows the results of representative CAT assays for the constructs displayed in the right half of this figure. Treatment of cells with PMA is indicated with + and -. The positions of nonacetylated and acetylated forms of [C]chloramphenicol are shown. The amount of protein assayed for CAT activity was chosen individually for each tested construct in order to obtain CAT conversion rates within the linear range. B, analysis of the DNA binding activity of two Gal4 fusion proteins. Plasmids encoding either Gal4-p65 or Gal4-p65 were transfected into COS cells. The cells were further treated as described for the experiments in A of this figure and assayed for DNA binding activity. EMSAs were performed by incubating equal amounts of protein with a P-labeled oligonucleotide containing a Gal4 binding site. The arrows point to specific DNAprotein complexes, the open triangle to the unbound DNA probe. C, a protein kinase C inhibitor abrogates the stimulatory effect of PMA on transactivation by Gal4-p65. COS cells were co-transfected with a Gal4-dependent reporter construct and Gal4-p65. After transfection, the cells were stimulated with PMA in the presence of the indicated amounts of the specific protein kinase C inhibitor bisindolylmaleimide. The results from a representative CAT assay are shown.



Since it is known that PMA stimulates the activity of protein kinase C, the effects of the protein kinase C inhibitor bisindolylmaleimide on PMA-activated transcription by Gal4-p65 were tested. COS cells co-transfected with a Gal4-dependent reporter construct and Gal4-p65 were treated simultaneously with 20 ng/ml PMA and various concentrations of bisindolylmaleimide. As evident from Fig. 5C, the inhibition of protein kinase C activity with 3 µM bisindolylmaleimide completely inhibited the stimulatory effect of PMA on transcription.

PMA Enhances Phosphorylation of TAin Intact Cells

We investigated whether the phorbol ester-inducible activation of TA correlates with an inducible phosphorylation of TA in response to PMA. COS cells were transiently transfected with a plasmid encoding either the DNA binding domain of Gal4 alone or fusion proteins between Gal4 and TA. Immunoprecipitation of Gal4-p65 revealed that this protein was phosphorylated in intact cells irrespective of PMA treatment of cells (Fig. 6A, compare lanes 1 and 2). The Gal4 protein alone showed no significant phosphorylation on its own, suggesting that phosphate was incorporated exclusively into the TA portion of the fusion protein. The correct expression of Gal4 and Gal4-p65 was verified by Western blotting (Fig. 6A, lanes 5-8). Similar experiments were performed with Gal4-p65. As is apparent in Fig. 6B (lanes 1 and 2), the constitutive phosphorylation of the Gal4-p65 fusion protein was enhanced after treatment of cells with PMA. Western blotting demonstrated the correct expression of Gal4-p65 to similar levels (Fig. 6B, lanes 3 and 4).


Figure 6: Both TADs of p65 are phosphorylated in vivo. A, TA is constitutively phosphorylated in vivo. An autoradiogram of immunoprecipitates using -Gal4 antibody is shown in lanes 1-4. Lanes 1 and 2 show the precipitation of Gal4-p65, lanes 3 and 4 the precipitation of Gal4. The presence of PMA is indicated with + or -. Arrows mark the positions of specific bands. Lanes 5-8 show a Western blot after incubation of the filters with an -Gal4 antibody and detection of bands with the ECL system. Lanes 5 and 6 show the expression of Gal4-p65; lanes 7 and 8 show the expression of Gal4. The molecular masses of prestained standards are shown in kilodaltons. For experimental details, see text. B, the PMA-responsive region of the TA domain is inducibly phosphorylated in vivo by phorbol ester. The autoradiogram of the immunoprecipitations (lanes 1 and 2) shows the bands obtained by precipitation of Gal4-p65. The Western blot (lanes 3 and 4) shows the correct expression of the proteins. The details of the figure legends are as explained in A of this figure.




DISCUSSION

The Structure of TA

In this study, we have further analyzed the transactivating C-terminal portion of the p65 (RelA) DNA-binding subunit of transcription factor NF-B. While the sequence requirements of TA in the 30 C-terminal residues of p65 have been studied in some detail (Schmitz et al., 1994; Blair et al., 1994), it was not known how the remaining transactivating sequences in p65 (referred to as TA) are structured and how they are related to TA. Here we show by a fine mapping analysis that TA cannot be further subdivided into autonomous transactivation domains without significant loss of activity. These results are not consistent with a previous study where the TA domain could be subdivided into a mini-leucine zipper region and a more C-terminal region, both of which displayed independent transcriptional activity (Moore et al., 1993). However, it remains to be clarified whether the different data are really conflicting, since the previous study did not numerically quantify the results of the transactivation assays. As shown here, Gal4 fusion proteins containing the region between the leucine zipper and TA are not highly active on their own. Only the entire TA domain has a strong transactivating potential similar to that of TA. In conclusion, the transactivating C terminus of p65 is highly redundant. It harbors two strong and fully independent TA domains. Deletion of either TA or TA leaves a strongly transactivating p65 C terminus.

Squelching experiments showed that TA, TA and the viral activator VP16 compete for the same co-activator molecules. This suggests that both TA and TA belong to the same class of acidic TA domains as VP16. We have previously reported (Schmitz et al., 1994) that TA and VP16 share sequence homology apart from containing a high percentage of acidic and hydrophobic amino acid residues. This finding prompted us to investigate also whether TA has a subdomain with sequence homology to TA (and VP16). In fact, such a homology region was present in TA and is referred to as TA`. Comparison of p65 proteins from different vertebrate species showed that TA` as well as TA domains are highly conserved allowing us to decipher a minimal consensus motif. The TA` subdomain in TA was essential for the activity of TA since its deletion strongly reduced the transactivating potential of TA. In contrast to TA, however, it was not independently active when fused to Gal4 but required flanking sequences for full activity.

Structure prediction programs and the absence of any -helix breaking proline and glycine residues suggested that the TA and TA` sequences form -helices. A CD and NMR analysis of TA showed a random coil structure (Schmitz et al., 1994). In the presence of hydrophobic solvents, TA adopted the expected -helical content. For the basic region of leucine zipper proteins, it was shown that -helices could only form if bound to DNA (Weiss et al., 1990). In analogy, we assume that acidic sequences may form an -helix only upon contacting target molecules by an ``induced fit'' mechanism. If TA and TA` sequences from different species are plotted on a helical wheel, a striking similarity is observed. Highly conserved positions with hydrophobic and acidic residues are found opposite of a helical surface which is rich in serine residues. This finding provides the basis for a further mutational analysis of these domains. An intriguing finding was that TA and TA` are each composed of two heptad repeat subdomains. These subdomains have recently been suggested to be necessary for proper functioning of the TA domain (Blair et al., 1994; Schmitz et al., 1994).

The repeat units are of functional importance because multimerized idealized repeats fused to Gal4 allowed the design of artificial activators. This finding suggests that the heptad repeats in TA and TA` acted synergistically, which is supported by a point mutation analysis of the TA repeats (Schmitz et al., 1994). We anticipate that each of the consensus repeats contacts a specific site on a target molecule. Only duplication makes the interaction between the repeats and their target sites strong enough to promote transcription. This hypothesis fits the ``simultaneous contact model'' proposed by Lin et al. (1990) and Carey et al.(1990). This model suggests that the repeats contact multiple, redundant sites within one molecule. Alternatively, each repeat could contact a separate molecule.

The multimer construct containing 6 consensus repeats failed to transactivate significantly stronger than that containing 4 repeats. Comparable results have also been obtained after multimerization experiments with the transactivation core domain of VP16 (Emanmi and Carey, 1992). Using a template bearing multiple Gal4 binding sites, this study showed that a synthetic activator containing four VP16 activation domains fused to Gal4 was transcriptionally not more active than Gal4 containing two copies of the VP16 core domain. This finding can be explained simply by the exhaustion of a limiting target factor. Alternatively it could be possible that the spacing between the respective repeats does not optimally fit the spatial requirements of the target molecule. A previous study on TA revealed that the repeats have to be properly spaced in order to optimally synergize (Schmitz et al., 1994). Insertion or deletion of a single amino acid in between the two repeats reduced the activity of TA by 90%. Likewise, introduction of a proline residue strongly interfered with TA activity, suggesting secondary structure constraints. The findings on TA, TA`, and VP16 indicate that acidic activators are not only characterized by a specific amino acid composition but also by a defined primary and secondary structure. Frequently, acidic activators contain Asp/Glu-Phe dipeptides flanked by additional acidic and hydrophobic residues (Schmitz et al., 1994; Tjian and Maniatis, 1994). In the case of TA and TA`, a high percentage of serine residues is seen. It appears that this hydroxyamino acid can functionally substitute for acidic residues. This is also evident from the artificial activators containing 4 and 6 copies of an idealized heptad repeat: they contain only one negatively charged amino acid per repeat. It is possible that in vivo additional negative charge is introduced by phosphorylation of serine residues which would allow us to modulate the transactivating potential of serine-rich acidic domains by protein kinases.

Phorbol Ester-dependent Activity of TA

Numerous transcription factors whose activity is regulated by external stimuli were found to contain inducible TADs. Enhancement of transcription involves in many cases phosphorylation of the TADs (reviewed by Jackson(1992) and Karin(1994)). A well-studied example is the phorbol ester-inducible activation domain in the N terminus of c-Jun. The enhanced activity of this TAD was found to correlate with PMA-induced phosphorylation of serines 63 and 73 (Franklin et al., 1992). These residues were shown to be phosphorylated by JNK1, a UV-inducible protein kinase (Dérijard et al., 1994). Another well defined example is the transcription factor CREB, which is involved in the cAMP-dependent signaling. Here, transcriptional activity is stimulated by cAMP-dependent protein kinase A which phosphorylates Ser-133 or, alternatively, by Ca-calmodulin-dependent protein kinases I and II (reviewed by Jackson, 1992). A positive transcriptional control by TAD phosphorylation is also seen with the SRF accessory protein Elk-1 (Marais et al., 1993) and transcription factor CREM (deGroot et al., 1993).

The increased activity of the p65 TA domain after stimulation with PMA correlates well with an increased phosphorylation of this region, suggesting that PMA-dependent phosphorylation enhances the transactivating potential of TA. The PMA-inducible region between amino acids 442 and 470 contains several potential phosphorylation sites (serines 457 and 468 and tyrosines 458 and 464). Future studies have to reveal whether PMA-activated protein kinase C is directly phosphorylating TA on serine or is initiating a signaling cascade involving other kinases. Another candidate kinase is casein kinase II (CKII), because there are several recognition sequences for this kinase in TA and TA. However, in vitro phosphorylation experiments with purified CKII and a bacterially expressed protein containing the C-terminal 123 amino acids of p65 failed to show phosphorylation by CKII. The p65 fragment containing both TADs was only phosphorylated up to 5%, whereas a control protein was quantitatively phosphorylated (data not shown). Another candidate is an uncharacterized serine/threonine kinase, which has been found associated with NF-B p65 (Ostrowski et al., 1991). This kinase might also be responsible for the increased phosphorylation of p65 seen after stimulation of HeLa cells with tumor necrosis factor- (Naumann and Scheidereit, 1994).

TA activity was only weakly responsive to phorbol ester stimulation, but was more highly phosphorylated than TA under control conditions. Because TA is devoid of threonine and tyrosine residues, it is most likely phosphorylated on serine residues within the conserved repeat domain. The conserved clustering of serines on one side of the potential -helix would restrict the increase in negative charge by phosphorylation to one helical surface. Since TA belongs to the class of acidic activators, additional negative charge introduced by phosphate groups may increase its transcriptional activity. Likewise, a controlled dephosphorylation could decrease the activity of TA.

Modulation of p65 activity by kinases and phosphatases which act on TA and TA superimposes a second level of regulation. The first one being binding of NF-B to its inhibitor IB in the cytoplasm. Phosphorylation of TA is likely to occur in the nucleus because it is observed with the Gal4 fusion protein, which does not undergo a phase of cytoplasmic storage as NF-B. Future studies are required to identify the sites of phosphorylation in TA and TA and the responsible kinases and phosphatases.


FOOTNOTES

*
This work was supported Grant SFB 190 from the Deutsche Forschungsgemeinschaft and grants from the Bundesministerium für Forschung und Technologie, the European Community (Biotechnology Programme) (to P. A. B.), and a Ph.D. fellowship from the Coordenadoria de Aperfeioamento de Pessoal de Ensino Superior (CAPES) (to M. d. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence and reprint requests should be addressed. Tel.: 49-761-203-5221; Fax: 49-761-203-5257.

Present address: Laboratório Multidisciplinar de Pesquisa em Doena de Chagas, Fac. de Cincias da Sade-UnB, Campus Universitrio, Caixa Postal 4685, 70919-970 Brasilia-DF, Brazil.

The abbreviations used are: NF-B, nuclear factor B; TAD, transactivation domain; PMA, phorbol 12-myristate 13-acetate; CAT, chloramphenicol acetyltransferase; EMSA, electrophoretic mobility shift assay.


ACKNOWLEDGEMENTS

We thank Heike Klein and Susanne Kunz for excellent technical assistance, Dr. Peter Angel (Karlsruhe) for the GHF expression vector, Dr. Georg Arnold (Martinsried) for synthesis of oligonucleotides, Dr. Brigitte Obermeier (Martinsried) for operating the automatic DNA sequencing device, Dr. Flavio Meggio (Padua) for purified CKII, Dr. Mark Ptashne (Cambridge, MA) for -Gal4 antibodies, and Dr. Kathy Tamai for helpful comments on the manuscript.


REFERENCES
  1. Baeuerle, P. A. & Baltimore, D. (1988) Science242, 540-546 [Abstract/Free Full Text]
  2. Baeuerle, P. A. & Henkel, T. (1994) Annu. Rev. Immunol.12, 141-179 [Medline] [Order article via Infotrieve]
  3. Ballard, D. W., Dixon, E. P., Peffer, N. J., Bogerd, H., Doerre, S., Stein, B. & Greene, W. C. (1992) Proc. Natl. Acad. Sci. U.S.A.89, 1875-1879 [Abstract/Free Full Text]
  4. Baniahmad, A., Köhne, A. C. & Renkawitz, R. (1992) EMBO J.11, 1015-1023 [Medline] [Order article via Infotrieve]
  5. Beg, A. A., Ruben, S. M., Scheinman, R. I., Haskill, S., Rosen, C. A. & Baldwin, A. S., Jr.(1992) Genes & Dev.6, 1899-1913
  6. Beg, A. A., Finco, T. S., Nantermet, P. V. & Baldwin, A. S., Jr. (1993) Mol. Cell. Biol.13, 3301-3310 [Abstract/Free Full Text]
  7. Berger, S. L., Pia, B., Silverman, N., Marcus, G. A., Agapite, J., Regier, J. L., Triezenberg, S. J. & Guarente, L. (1992) Cell70, 251-265 [CrossRef][Medline] [Order article via Infotrieve]
  8. Blair, W. S., Bogerd, H. P., Madore, S. J. & Cullen, B. R. (1994) Mol. Cell. Biol.14, 7226-7234 [Abstract/Free Full Text]
  9. Blank, V., Kourilsky, P. & Isral, A. (1992) Trends Biochem. Sci.17, 135-140 [CrossRef][Medline] [Order article via Infotrieve]
  10. Bradford, M. (1976) Anal. Biochem.72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  11. Bull, P., Morley, K. L., Hoekstra, M. F., Hunter, T. & Verma, I. M. (1990) Mol. Cell. Biol.10, 5473-5485 [Abstract/Free Full Text]
  12. Carey, M., Lin, Y.-S., Green, M. R. & Ptashne, M. (1990) Nature345, 361-364 [CrossRef][Medline] [Order article via Infotrieve]
  13. Croston, G. E., Kerrigan, L. A., Lira, L. M., Marshak, D. R. & Kadonaga, J. T. (1991) Science251, 643-649 [Abstract/Free Full Text]
  14. deGroot, R. P., den Hertog, J., Vandenheede, J. R., Goris, J. & Sassone-Corsi, P. (1993) EMBO J.12, 3903-3911 [Medline] [Order article via Infotrieve]
  15. Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M. & Davis, R. J. (1994) Cell76, 1025-1037 [CrossRef][Medline] [Order article via Infotrieve]
  16. Donaldson, L. & Capone, J. P. (1992) J. Biol. Chem.267, 1411-1414 [Abstract/Free Full Text]
  17. Emami, K. H. & Carey, M. (1992) EMBO J.11, 5005-5012 [Medline] [Order article via Infotrieve]
  18. Franklin, C. C., Sanchez, V., Wagner, F., Woodgett, J. R. & Kraft, A. S. (1992) Proc. Natl. Acad. Sci. U.S.A.89, 7247-7251 [Abstract/Free Full Text]
  19. Fujita, T., Nolan, G. P., Gosh, S. & Baltimore, D. (1992) Genes & Dev.6, 775-787
  20. Giniger, E. & Ptashne, M. (1987) Nature330, 670-673 [CrossRef][Medline] [Order article via Infotrieve]
  21. Goodrich, J. A., Hoey, T., Thut, C. J., Admon, A. & Tjian, R. (1993) Cell75, 519-530 [CrossRef][Medline] [Order article via Infotrieve]
  22. Grilli, M., Chiu, J. J. & Lenardo, M. J. (1993) Int. Rev. Cytol.143, 1-62 [Medline] [Order article via Infotrieve]
  23. Henkel, T., Machleidt, T., Alkalay, I., Ben-Neriah, Y., Krönke, K. M. & Baeuerle, P. A. (1993) Nature365, 182-184 [CrossRef][Medline] [Order article via Infotrieve]
  24. Hoey, T., Weinzierl, R. O. J., Gill, G., Chen, J.-L., Dynlacht, B. D. & Tjian, R. (1993) Cell72, 247-260 [CrossRef][Medline] [Order article via Infotrieve]
  25. Jackson, S. P. (1992) Trends Cell Biol.2, 104-108
  26. Kao, K. R. & Hopwood, N. D. (1991) Proc. Natl. Acad. Sci. U.S.A.88, 2697-2701 [Abstract/Free Full Text]
  27. Karin, M. (1994) Curr. Opin. Cell Biol.6, 415-424 [CrossRef][Medline] [Order article via Infotrieve]
  28. Leuther, K. K., Salmeron, J. M. & Johnston, S. A. (1993) Cell72, 575-585 [CrossRef][Medline] [Order article via Infotrieve]
  29. Lin, Y.-S., Carey, M., Ptashne, M. & Green, M. R. (1990) Nature345, 359-361 [CrossRef][Medline] [Order article via Infotrieve]
  30. Lin, Y.-S., Ha, I., Maldonado, E., Reinberg, D. & Green, M. R. (1991) Nature353, 569-571 [CrossRef][Medline] [Order article via Infotrieve]
  31. Liou, H.-C. & Baltimore, D. (1993) Curr. Opin. Cell Biol.5, 477-487 [CrossRef][Medline] [Order article via Infotrieve]
  32. Lopata, M. A., Cleveland, D. W. & Sollner-Webb, B. (1984) Nucleic Acids Res.12, 5707-5717 [Abstract/Free Full Text]
  33. Marais, R., Wynne, J. & Treisman, R. (1993) Cell73, 381-393 [CrossRef][Medline] [Order article via Infotrieve]
  34. Mitchell, P. J. & Tjian, R. (1989) Science245, 371-378 [Abstract/Free Full Text]
  35. Moore, P. A., Ruben, S. M. & Rosen, C. A. (1993) Mol. Cell. Biol.13, 1666-1674 [Abstract/Free Full Text]
  36. Naumann, M. & Scheidereit, C. (1994) EMBO J.13, 4597-4607 [Medline] [Order article via Infotrieve]
  37. Nolan, G. P., Ghosh, S., Liou, H.-C., Tempst, P. & Baltimore, D. (1991) Cell64, 961-969 [CrossRef][Medline] [Order article via Infotrieve]
  38. Ostrowski, J., Sims, J. E., Sibley, C. H., Valentine, M. A., Dower, S. K., Meier, K. E. & Bomsztyk, K. (1991) J. Biol. Chem.266, 12722-12733 [Abstract/Free Full Text]
  39. Pierce, J. W., Lenardo, M. & Baltimore, D. (1988) Proc. Natl. Acad. Sci. U.S.A.85, 1482-1486 [Abstract/Free Full Text]
  40. Ptashne, M. (1988) Nature335, 683-689 [CrossRef][Medline] [Order article via Infotrieve]
  41. Ruben, S. M., Dillon, P. J., Schreck, R., Henkel, T., Chen, C.-H., Maher, M., Baeuerle, P. A. & Rosen, C. A. (1991) Science251, 1490-1493 [Abstract/Free Full Text]
  42. Ruben, S. M., Narayanan, R., Klement, J. F., Chen, C.-H. & Rosen, C. A. (1992) Mol. Cell. Biol.12, 444-454 [Abstract/Free Full Text]
  43. Rysek, R. P., Bull, P., Takamiya, M., Bours, V., Siebenlist, U., Dobrzanski, P. & Bravo, R. (1992) Mol. Cell. Biol.12, 674-684 [Abstract/Free Full Text]
  44. Schmitz, M. L. & Baeuerle, P. A. (1991) EMBO J.10, 3805-3817 [Medline] [Order article via Infotrieve]
  45. Schmitz, M. L. & Baeuerle, P. A. (1995) Immunobiology, in press
  46. Schmitz, M. L., dos Santos Silva, M. A., Altmann, H., Czisch, M., Holak, T. A. & Baeuerle, P. A. (1994) J. Biol. Chem.269, 25613-25620 [Abstract/Free Full Text]
  47. Seipel, K., Georgiev, O. & Schaffner, W. (1992) EMBO J.11, 4961-4968 [Medline] [Order article via Infotrieve]
  48. Sigler, P. B. (1988) Nature331, 210-212
  49. Stringer, K. F., Ingles, C. J. & Greenblatt, J. (1990) Nature345, 783-786 [CrossRef][Medline] [Order article via Infotrieve]
  50. Sun, S. C., Ganchi, P. A., Ballard, D. W. & Greene, W. C. (1993) Science259, 1912-1915 [Abstract/Free Full Text]
  51. Thanos, D. & Maniatis, T. (1995) Cell80, 529-532 [CrossRef][Medline] [Order article via Infotrieve]
  52. Theill, L. E., Castrillo, J. L., Wu, D. & Karin, M. (1989) Nature342, 945-948 [CrossRef][Medline] [Order article via Infotrieve]
  53. Tjian, R. & Maniatis, T. (1994) Cell77, 5-8 [CrossRef][Medline] [Order article via Infotrieve]
  54. Van Hoy, M., Leuther, K. K., Kodadek, T. & Johnston, S. A. (1993) Cell72, 587-594 [CrossRef][Medline] [Order article via Infotrieve]
  55. Weiss, M. A., Ellenberger, T., Wobbe, C. R., Lee, J. P., Harrison, S. C. & Struhl, K. (1990) Nature347, 575-578 [CrossRef][Medline] [Order article via Infotrieve]
  56. Zabel, U., Henkel, T., dos Santos Silva, M. & Baeuerle, P. A. (1993) EMBO J.12, 201-211 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
S. Choudhary, M. Lu, R. Cui, and A. R. Brasier
Involvement of a Novel Rac/RhoA Guanosine Triphosphatase-Nuclear Factor-{kappa}B Inducing Kinase Signaling Pathway Mediating Angiotensin II-Induced RelA Transactivation
Mol. Endocrinol., September 1, 2007; 21(9): 2203 - 2217.